NPI: 1821058652 · LANHAM, MD 20706 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,785 | $19K |
| 2019 | 12,185 | $80K |
| 2020 | 9,321 | $140K |
| 2021 | 13,258 | $210K |
| 2022 | 11,750 | $209K |
| 2023 | 8,327 | $268K |
| 2024 | 5,892 | $197K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,902 | 1,925 | $754K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 912 | 541 | $185K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,663 | 1,290 | $119K |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,142 | 1,027 | $36K |
| J1756 | Injection, iron sucrose, 1 mg | 5,157 | 1,402 | $20K |
| 83970 | 1,665 | 1,502 | $8K | |
| A4657 | Syringe, with or without needle, each | 2,708 | 1,928 | $894.96 |
| 85041 | 1,801 | 1,640 | $0.00 | |
| 83540 | 968 | 861 | $0.00 | |
| 85048 | 1,753 | 1,596 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,136 | 552 | $0.00 |
| 82728 | 945 | 851 | $0.00 | |
| 83550 | 753 | 673 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $0.00 |